Genetic susceptibility to type 2 diabetes and obesity: Follow-up of findings from genome-wide association studies

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Basile, Kevin J ^a   Johnson, Matthew E ^a   Xia, Qianghua ^a   Grant, Struan F A ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAT MASS AND OBESITY ASSOCIATED PROTEIN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG;

BODY MASS; CHILDHOOD OBESITY; CHROMATIN IMMUNOPRECIPITATION; COPY NUMBER VARIATION; DIABETOGENESIS; DRUG RESPONSE; FOLLOW UP; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HERITABILITY; HUMAN; LINKAGE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84897846868     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/769671     Document Type: Review

References (139)

1. International HapMap Consortium, The International HapMap Project. Nature 2003 426 6968 789 796 10.1038/nature02168 (Pubitemid 38056856)
2. International HapMap Consortium, A haplotype map of the human genome. Nature 2005 437 7063 1299 1320 10.1038/nature04226 (Pubitemid 41568671)
3. Gunderson K. L., Steemers F. J., Lee G., Mendoza L. G., Chee M. S., A genome-wide scalable SNP genotyping assay using microarray technology. Nature Genetics 2005 37 5 549 554 2-s2.0-18144425478 10.1038/ng1547 (Pubitemid 40617286)
4. Reich D., Patterson N., De Jager P. L., McDonald G. J., Waliszewska A., Tandon A., Lincoln R. R., DeLoa C., Fruhan S. A., Cabre P., Bera O., Semana G., Kelly M. A., Francis D. A., Ardlie K., Khan O., Cree B. A. C., Hauser S. L., Oksenberg J. R., Hafler D. A., A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nature Genetics 2005 37 10 1113 1118 2-s2.0-27144472560 10.1038/ng1646 (Pubitemid 41486665)
5. Steemers F. J., Chang W., Lee G., Barker D. L., Shen R., Gunderson K. L., Whole-genome genotyping with the single-base extension assay. Nature Methods 2006 3 1 31 33 2-s2.0-31344476038 10.1038/nmeth842 (Pubitemid 43135346)
6. Moffatt M. F., Kabesch M., Liang L., Dixon A. L., Strachan D., Heath S., Depner M., Von Berg A., Bufe A., Rietschel E., Heinzmann A., Simma B., Frischer T., Willis-Owen S. A. G., Wong K. C. C., Illig T., Vogelberg C., Weiland S. K., Von Mutius E., Abecasis G. R., Farrall M., Gut I. G., Lathrop G. M., Cookson W. O. C., Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007 448 7152 470 473 2-s2.0-34547216747 10.1038/nature06014 (Pubitemid 47123521)
7. Sleiman P. M., Flory J., Imielinski M., Variants of DENND1B associated with asthma in children. The New England Journal of Medicine 2010 362 1 36 44 10.1056/NEJMoa0901867
8. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T., Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nature Genetics 2009 41 12 1303 1307 2-s2.0-70549084415 10.1038/ng.485
9. Simon-Sanchez J., Schulte C., Bras J. M., Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics 2009 41 12 1308 1312 10.1038/ng.487
10. Wang K., Zhang H., Ma D., Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009 459 7246 528 533 10.1038/nature07999
11. Altshuler D., Hirschhorn J. N., Klannemark M., Lindgren C. M., Vohl M.-C., Nemesh J., Lane C. R., Schaffner S. F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T. J., Daly M., Groop L., Lander E. S., The common PPAR γ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 2000 26 1 76 80 2-s2.0-0033624575 10.1038/79216
12. Gloyn A. L., Weedon M. N., Owen K. R., Turner M. J., Knight B. A., Hitman G., Walker M., Levy J. C., Sampson M., Halford S., McCarthy M. I., Hattersley A. T., Frayling T. M., Large-scale association studies of variants in genes encoding the pancreatic β -cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003 52 2 568 572 2-s2.0-0037317981 10.2337/diabetes.52.2.568 (Pubitemid 36173218)
13. Horikawa Y., Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nature Genetics 2000 26 2 163 175 10.1038/79876
14. Dupuis J., Langenberg C., Prokopenko I., New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics 2010 42 2 105 116 10.1038/ng.520
15. Gudmundsson J., Sulem P., Steinthorsdottir V., Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nature Genetics 2007 39 8 977 983 10.1038/ng2062 (Pubitemid 47185170)
16. Rung J., Cauchi S., Albrechtsen A., Shen L., Rocheleau G., Cavalcanti-Proença C., Bacot F., Balkau B., Belisle A., Borch-Johnsen K., Charpentier G., Dina C., Durand E., Elliott P., Hadjadj S., Järvelin M.-R., Laitinen J., Lauritzen T., Marre M., Mazur A., Meyre D., Montpetit A., Pisinger C., Posner B., Poulsen P., Pouta A., Prentki M., Ribel-Madsen R., Ruokonen A., Sandbaek A., Serre D., Tichet J., Vaxillaire M., Wojtaszewski J. F. P., Vaag A., Hansen T., Polychronakos C., Pedersen O., Froguel P., Sladek R., Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nature Genetics 2009 41 10 1110 1115 2-s2.0-70349557826 10.1038/ng.443
17. Saxena R., Voight B. F., Lyssenko V., Burtt N. P., De Bakker P. I. W., Chen H., Roix J. J., Kathiresan S., Hirschhorn J. N., Daly M. J., Hughes T. E., Groop L., Altshuler D., Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007 316 5829 1331 1336 2-s2.0-34249888775 10.1126/science.1142358 (Pubitemid 46871653)
18. Scott L. J., Mohlke K. L., Bonnycastle L. L., Willer C. J., Li Y., Duren W. L., Erdos M. R., Stringham H. M., Chines P. S., Jackson A. U., Prokunina-Olsson L., Ding C.-J., Swift A. J., Narisu N., Hu T., Pruim R., Xiao R., Li X.-Y., Conneely K. N., Riebow N. L., Sprau A. G., Tong M., White P. P., Hetrick K. N., Barnhart M. W., Bark C. W., Goldstein J. L., Watkins L., Xiang F., Saramies J., Buchanan T. A., Watanabe R. M., Valle T. T., Kinnunen L., Abecasis G. R., Pugh E. W., Doheny K. F., Bergman R. N., Tuomilehto J., Collins F. S., Boehnke M., A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants. Science 2007 316 5829 1341 1345 2-s2.0-34249885875 10.1126/science.1142382 (Pubitemid 46871655)
19. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T. J., Montpetit A., Pshezhetsky A. V., Prentki M., Posner B. I., Balding D. J., Meyre D., Polychronakos C., Froguel P., A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007 445 7130 881 885 2-s2.0-33847176604 10.1038/nature05616
20. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., Benediktsson R., Jonsdottir T., Walters G. B., Styrkarsdottir U., Gretarsdottir S., Emilsson V., Ghosh S., Baker A., Snorradottir S., Bjarnason H., Ng M. C. Y., Hansen T., Bagger Y., Wilensky R. L., Reilly M. P., Adeyemo A., Chen Y., Zhou J., Gudnason V., Chen G., Huang H., Lashley K., Doumatey A., So W.-Y., Ma R. C. Y., Andersen G., Borch-Johnsen K., Jorgensen T., Van Vliet-Ostaptchouk J. V., Hofker M. H., Wijmenga C., Christiansen C., Rader D. J., Rotimi C., Gurney M., Chan J. C. N., Pedersen O., Sigurdsson G., Gulcher J. R., Thorsteinsdottir U., Kong A., Stefansson K., A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nature Genetics 2007 39 6 770 775 2-s2.0-34249828965 10.1038/ng2043 (Pubitemid 46848592)
21. Unoki H., Takahashi A., Kawaguchi T., Hara K., Horikoshi M., Andersen G., Ng D. P. K., Holmkvist J., Borch-Johnsen K., Jørgensen T., Sandbæk A., Lauritzen T., Hansen T., Nurbaya S., Tsunoda T., Kubo M., Babazono T., Hirose H., Hayashi M., Iwamoto Y., Kashiwagi A., Kaku K., Kawamori R., Tai E. S., Pedersen O., Kamatani N., Kadowaki T., Kikkawa R., Nakamura Y., Maeda S., SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nature Genetics 2008 40 9 1098 1102 2-s2.0-50449085212 10.1038/ng.208
22. Voight B. F., Scott L. J., Steinthorsdottir V., Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nature Genetics 2010 42 7 579 589 10.1038/ng.609
23. Burton P. R., Clayton D. G., Cardon L. R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D. P., McCarthy M. I., Ouwehand W. H., Samani N. J., Todd J. A., Donnelly P., Barrett J. C., Davison D., Easton D., Evans D., Leung H.-T., Marchini J. L., Morris A. P., Spencer C. C. A., Tobin M. D., Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 447 7145 661 678 2-s2.0-34250025139 10.1038/nature05911 (Pubitemid 46889737)
24. Yasuda K., Miyake K., Horikawa Y., Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nature Genetics 2008 40 9 1092 1097 10.1038/ng.207
25. Zeggini E., Scott L. J., Saxena R., Voight B. F., Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nature Genetics 2008 40 5 638 645 2-s2.0-42349106044 10.1038/ng.120 (Pubitemid 351601209)
26. Zeggini E., Weedon M. N., Lindgren C. M., Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007 316 5829 1336 1341 10.1126/science.1142364 (Pubitemid 46871654)
27. Bouatia-Naji N., Bonnefond A., Cavalcanti-Proença C., Sparsø T., Holmkvist J., Marchand M., Delplanque J., Lobbens S., Rocheleau G., Durand E., De Graeve F., Chèvre J.-C., Borch-Johnsen K., Hartikainen A.-L., Ruokonen A., Tichet J., Marre M., Weill J., Heude B., Tauber M., Lemaire K., Schuit F., Elliott P., Jørgensen T., Charpentier G., Hadjadj S., Cauchi S., Vaxillaire M., Sladek R., Visvikis-Siest S., Balkau B., Lévy-Marchal C., Pattou F., Meyre D., Blakemore A. I. F., Jarvelin M.-R., Walley A. J., Hansen T., Dina C., Pedersen O., Froguel P., A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nature Genetics 2009 41 1 89 94 2-s2.0-58149175143 10.1038/ng.277
28. Lyssenko V., Nagorny C. L. F., Erdos M. R., Wierup N., Jonsson A., Spégel P., Bugliani M., Saxena R., Fex M., Pulizzi N., Isomaa B., Tuomi T., Nilsson P., Kuusisto J., Tuomilehto J., Boehnke M., Altshuler D., Sundler F., Eriksson J. G., Jackson A. U., Laakso M., Marchetti P., Watanabe R. M., Mulder H., Groop L., Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nature Genetics 2009 41 1 82 88 2-s2.0-58149175669 10.1038/ng.288
29. Prokopenko I., Langenberg C., Florez J. C., Variants in MTNR1B influence fasting glucose levels. Nature Genetics 2009 41 1 77 81 10.1038/ng.290
30. Frayling T. M., Timpson N. J., Weedon M. N., Zeggini E., Freathy R. M., Lindgren C. M., Perry J. R. B., Elliott K. S., Lango H., Rayner N. W., Shields B., Harries L. W., Barrett J. C., Ellard S., Groves C. J., Knight B., Patch A.-M., Ness A. R., Ebrahim S., Lawlor D. A., Ring S. M., Ben-Shlomo Y., Jarvelin M.-R., Sovio U., Bennett A. J., Melzer D., Ferrucci L., Loos R. J. F., Barroso I., Wareham N. J., Karpe F., Owen K. R., Cardon L. R., Walker M., Hitman G. A., Palmer C. N. A., Doney A. S. F., Morris A. D., Smith G. D., Hattersley A. T., McCarthy M. I., A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007 316 5826 889 894 2-s2.0-34248594090 10.1126/science.1141634 (Pubitemid 46764279)
31. Grant S. F. A., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K. P., Walters G. B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R. L., Reilly M. P., Rader D. J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J. R., Kong A., Stefansson K., Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 2006 38 3 320 323 2-s2.0-32544451924 10.1038/ng1732
32. Cauchi S., El Achhab Y., Choquet H., Dina C., Krempler F., Weitgasser R., Nejjari C., Patsch W., Chikri M., Meyre D., Froguel P., TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. Journal of Molecular Medicine 2007 85 7 777 782 2-s2.0-34447340935 10.1007/s00109-007-0203-4 (Pubitemid 47063530)
33. Lango Allen H., Estrada K., Lettre G., Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010 467 7317 832 838 10.1038/nature09410
34. Cho Y. S., Chen C. H., Hu C., Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in East Asians. Nature Genetics 2011 44 1 67 72 10.1038/ng.1019
35. Kooner J. S., Saleheen D., Sim X., Sehmi J., Zhang W., Frossard P., Been L. F., Chia K.-S., Dimas A. S., Hassanali N., Jafar T., Jowett J. B. M., Li X., Radha V., Rees S. D., Takeuchi F., Young R., Aung T., Basit A., Chidambaram M., Das D., Grundberg E., Hedman Å. K., Hydrie Z. I., Islam M., Khor C.-C., Kowlessur S., Kristensen M. M., Liju S., Lim W.-Y., Matthews D. R., Liu J., Morris A. P., Nica A. C., Pinidiyapathirage J. M., Prokopenko I., Rasheed A., Samuel M., Shah N., Shera A. S., Small K. S., Suo C., Wickremasinghe A. R., Wong T. Y., Yang M., Zhang F., Abecasis G. R., Barnett A. H., Deloukas P., Frayling T. M., Froguel P., Kato N., Katulanda P., Kelly M. A., Liang J., Mohan V., Sanghera D. K., Scott J., Seielstad M., Zimmet P. Z., Elliott P., Teo Y. Y., McCarthy M. I., Danesh J., Tai E. S., Chambers J. C., Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nature Genetics 2011 43 10 984 989 2-s2.0-80053385333 10.1038/ng.921
36. The SIGMA Type 2 Diabetes Consortium, Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 2013 10.1038/nature12828
37. Dickson S. P., Wang K., Krantz I., Hakonarson H., Goldstein D. B., Rare variants create synthetic genome-wide associations. PLoS Biology 2010 8 1 e1000294 2-s2.0-77249134594 10.1371/journal.pbio.1000294
38. Wang K., Dickson S. P., Stolle C. A., Krantz I. D., Goldstein D. B., Hakonarson H., Interpretation of association signals and identification of causal variants from genome-wide association studies. The American Journal of Human Genetics 2010 86 5 730 742 2-s2.0-77951974619 10.1016/j.ajhg.2010.04.003
39. Craddock N., Hurles M. E., Cardin N., Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010 464 7289 713 720 10.1038/nature08979
40. Hattersley A. T., Tooke J. E., The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. The Lancet 1999 353 9166 1789 1792 2-s2.0-0033594787 10.1016/S0140-6736(98)07546-1 (Pubitemid 29240389)
41. Slingerland A. S., Hattersley A. T., Activating mutations in the gene encoding Kir6.2 alter fetal and postnatal growth and also cause neonatal diabetes. Journal of Clinical Endocrinology and Metabolism 2006 91 7 2782 2788 2-s2.0-33745778040 10.1210/jc.2006-0201 (Pubitemid 44024651)
42. Støy J., Edghill E. L., Flanagan S. E., Ye H., Paz V. P., Pluzhnikov A., Below J. E., Hayes M. G., Cox N. J., Lipkind G. M., Lipton R. B., Greeley S. A. W., Patch A.-M., Ellard S., Steiner D. F., Hattersley A. T., Philipson L. H., Bell G. I., Insulin gene mutations as a cause of permanent neonatal diabetes. Proceedings of the National Academy of Sciences of the United States of America 2007 104 38 15040 15044 2-s2.0-35448994352 10.1073/pnas.0707291104 (Pubitemid 47619589)
43. Andersson E. A., Pilgaard K., Pisinger C., Harder M. N., Grarup N., Færch K., Poulsen P., Witte D. R., Jørgensen T., Vaag A., Hansen T., Pedersen O., Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight. Diabetologia 2010 53 9 1908 1916 2-s2.0-77955558577 10.1007/s00125-010-1790-0
44. Freathy R. M., Bennett A. J., Ring S. M., Shields B., Groves C. J., Timpson N. J., Weedon M. N., Zeggini E., Lindgren C. M., Lango H., Perry J. R. B., Pouta A., Ruokonen A., Hyppönen E., Power C., Elliott P., Strachan D. P., Järvelin M.-R., Smith G. D., McCarthy M. I., Frayling T. M., Hattersley A. T., Type 2 diabetes risk alleles are associated with reduced size at birth. Diabetes 2009 58 6 1428 1433 2-s2.0-66649099906 10.2337/db08-1739
45. Freathy R. M., Mook-Kanamori D. O., Sovio U., Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nature Genetics 2010 42 5 430 435 10.1038/ng.567
46. Pulizzi N., Lyssenko V., Jonsson A., Osmond C., Laakso M., Kajantie E., Barker D. J., Groop L. C., Eriksson J. G., Interaction between prenatal growth and high-risk genotypes in the development of type 2 diabetes. Diabetologia 2009 52 5 825 829 2-s2.0-64149117551 10.1007/s00125-009-1291-1
47. Zhao J., Li M., Bradfield J. P., Wang K., Zhang H., Sleiman P., Kim C. E., Annaiah K., Glaberson W., Glessner J. T., Otieno F. G., Thomas K. A., Garris M., Hou C., Frackelton E. C., Chiavacci R. M., Berkowitz R. I., Hakonarson H., Grant S. F. A., Examination of type 2 diabetes loci implicates CDKAL1 as a birth weight gene. Diabetes 2009 58 10 2414 2418 2-s2.0-70349642876 10.2337/db09-0506
48. Zhao J., Bradfield J. P., Zhang H., Annaiah K., Wang K., Kim C. E., Glessner J. T., Frackelton E. C., Otieno F. G., Doran J., Thomas K. A., Garris M., Hou C., Chiavacci R. M., Li M., Berkowitz R. I., Hakonarson H., Grant S. F. A., Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI. Diabetes 2010 59 3 751 755 2-s2.0-77950357948 10.2337/db09-0972
49. Florez J. C., Burtt N., De Bakker P. I. W., Almgren P., Tuomi T., Holmkvist J., Gaudet D., Hudson T. J., Schaffner S. F., Daly M. J., Hirschhorn J. N., Groop L., Altshuler D., Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the Islet ATP-sensitive potassium channel gene region. Diabetes 2004 53 5 1360 1368 2-s2.0-2342561802 10.2337/diabetes.53.5.1360 (Pubitemid 38569024)
50. Meigs J. B., Shrader P., Sullivan L. M., McAteer J. B., Fox C. S., Dupuis J., Manning A. K., Florez J. C., Wilson P. W. F., D'Agostino R. B. Sr., Cupples L. A., Genotype score in addition to common risk factors for prediction of type 2 diabetes. The New England Journal of Medicine 2008 359 21 2208 2219 2-s2.0-56749101779 10.1056/NEJMoa0804742
51. Lyssenko V., Jonsson A., Almgren P., Pulizzi N., Isomaa B., Tuomi T., Berglund G., Altshuler D., Nilsson P., Groop L., Clinical risk factors, DNA variants, and the development of type 2 diabetes. The New England Journal of Medicine 2008 359 21 2220 2232 2-s2.0-55649105963 10.1056/NEJMoa0801869
52. De Miguel-Yanes J. M., Shrader P., Pencina M. J., Fox C. S., Manning A. K., Grant R. W., Dupuis J., Florez J. C., D'Agostino R. B., Cupples L. A., Meigs J. B., Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 2011 34 1 121 125 2-s2.0-79951715822 10.2337/dc10-1265
53. Hivert M.-F., Jablonski K. A., Perreault L., Saxena R., McAteer J. B., Franks P. W., Hamman R. F., Kahn S. E., Haffner S., Meigs J. B., Altshuler D., Knowler W. C., Florez J. C., Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the Diabetes Prevention Program. Diabetes 2011 60 4 1340 1348 2-s2.0-79953216697 10.2337/db10-1119
54. Andersson E. A., Allin K. H., Sandholt C. H., Genetic risk socre of 46 type 2 diabetes risk variants with changes in plasma glucose and estimates of pancreatic?-cell function over 5 years of follow-up. Diabetes 2013 62 10 3610 3617 10.2337/db13-0362
55. Morris A. P., Voight B. F., Teslovich T. M., Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature Genetics 2012 44 9 981 990 10.1038/ng.2383
56. Duval A., Gayet J., Zhou X.-P., Iacopetta B., Thomas G., Hamelin R., Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Research 1999 59 17 4213 4215 2-s2.0-0033198994 (Pubitemid 29418728)
57. Duval A., Rolland S., Tubacher E., Bui H., Thomas G., Hamelin R., The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Research 2000 60 14 3872 3879 2-s2.0-0034660872 (Pubitemid 32204580)
58. Bass A. J., Lawrence M. S., Brace L. E., Ramos A. H., Drier Y., Cibulskis K., Sougnez C., Voet D., Saksena G., Sivachenko A., Jing R., Parkin M., Pugh T., Verhaak R. G., Stransky N., Boutin A. T., Barretina J., Solit D. B., Vakiani E., Shao W., Mishina Y., Warmuth M., Jimenez J., Chiang D. Y., Signoretti S., Kaelin W. G. Jr., Spardy N., Hahn W. C., Hoshida Y., Ogino S., Depinho R. A., Chin L., Garraway L. A., Fuchs C. S., Baselga J., Tabernero J., Gabriel S., Lander E. S., Getz G., Meyerson M., Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nature Genetics 2011 43 10 964 970 2-s2.0-80053385552 10.1038/ng.936
59. Frayling T. M., Colhoun H., Florez J. C., A genetic link between type 2 diabetes and prostate cancer. Diabetologia 2008 51 10 1757 1760 2-s2.0-51249110837 10.1007/s00125-008-1114-9
60. Thomas G., Jacobs K. B., Yeager M., Multiple loci identified in a genome-wide association study of prostate cancer. Nature Genetics 2008 40 3 310 315 10.1038/ng.91 (Pubitemid 351311773)
61. Neve B., Fernandez-Zapico M. E., Ashkenazi-Katalan V., Dina C., Hamid Y. H., Joly E., Vaillant E., Benmezroua Y., Durand E., Bakaher N., Delannoy V., Vaxillaire M., Cook T., Dallinga-Thie G. M., Jansen H., Charles M.-A., Clément K., Galan P., Hercberg S., Helbecque N., Charpentier G., Prentki M., Hansen T., Pedersen O., Urrutia R., Melloul D., Froguel P., Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proceedings of the National Academy of Sciences of the United States of America 2005 102 13 4807 4812 2-s2.0-20144389645 10.1073/pnas.0409177102 (Pubitemid 40471535)
62. Plengvidhya N., Kooptiwut S., Songtawee N., Doi A., Furuta H., Nishi M., Nanjo K., Tantibhedhyangkul W., Boonyasrisawat W., Yenchitsomanus P.-T., Doria A., Banchuin N., Brief report: PAX4 mutations in Thais with maturity onset diabetes of the young. Journal of Clinical Endocrinology and Metabolism 2007 92 7 2821 2826 2-s2.0-34447132254 10.1210/jc.2006-1927 (Pubitemid 47037395)
63. Borowiec M., Liew C. W., Thompson R., Boonyasrisawat W., Hu J., Mlynarski W. M., El Khattabi I., Kim S.-H., Marselli L., Rich S. S., Krolewski A. S., Bonner-Weir S., Sharma A., Sale M., Mychaleckyj J. C., Kulkarni R. N., Doria A., Mutations at the BLK locus linked to maturity onset diabetes of the young and β -cell dysfunction. Proceedings of the National Academy of Sciences of the United States of America 2009 106 34 14460 14465 2-s2.0-70149104834 10.1073/pnas.0906474106
64. Thanabalasingham G., Owen K. R., Diagnosis and management of maturity onset diabetes of the young (MODY). British Medical Journal 2011 343, article d6044 10.1136/bmj.d6044 2-s2.0-80054844566
65. Kavvoura F. K., Owen K. R., Maturity onset diabetes of the young: clinical characteristics, diagnosis and management. Pediatric Endocrinology Reviews 2012 10 2 234 242
66. Hani E. H., Stoffers D. A., Chèvre J.-C., Durand E., Stanojevic V., Dina C., Habener J. F., Froguel P., Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. Journal of Clinical Investigation 1999 104 9 R41 R48 2-s2.0-0032718689 (Pubitemid 29536303)
67. Macfarlane W. M., Frayling T. M., Ellard S., Evans J. C., Allen L. I. S., Bulman M. P., Ayres S., Shepherd M., Clark P., Millward A., Demaine A., Wilkin T., Docherty K., Hattersley A. T., Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. Journal of Clinical Investigation 1999 104 9 R33 R39 2-s2.0-0032742985 (Pubitemid 29536302)
68. Hegele R. A., Cao H., Harris S. B., Hanley A. J. G., Zinman B., The hepatic nuclear factor-1 α G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. Journal of Clinical Endocrinology and Metabolism 1999 84 3 1077 1082 2-s2.0-0033027001 (Pubitemid 29138246)
69. Barrett J. C., Clayton D. G., Concannon P., Akolkar B., Cooper J. D., Erlich H. A., Julier C., Morahan G., Nerup J., Nierras C., Plagnol V., Pociot F., Schuilenburg H., Smyth D. J., Stevens H., Todd J. A., Walker N. M., Rich S. S., Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nature Genetics 2009 41 6 703 707 2-s2.0-67349199566 10.1038/ng.381
70. Bradfield J. P., Qu H.-Q., Wang K., Zhang H., Sleiman P. M., Kim C. E., Mentch F. D., Qiu H., Glessner J. T., Thomas K. A., Frackelton E. C., Chiavacci R. M., Imielinski M., Monos D. S., Pandey R., Bakay M., Grant S. F. A., Polychronakos C., Hakonarson H., A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genetics 2011 7 9 2-s2.0-80053439315 10.1371/journal.pgen.1002293 e1002293
71. Cooper J. D., Smyth D. J., Smiles A. M., Plagnol V., Walker N. M., Allen J. E., Downes K., Barrett J. C., Healy B. C., Mychaleckyj J. C., Warram J. H., Todd J. A., Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nature Genetics 2008 40 12 1399 1401 2-s2.0-56749183605 10.1038/ng.249
72. Grant S. F. A., Li M., Bradfield J. P., Kim C. E., Annaiah K., Santa E., Glessner J. T., Casalunovo T., Frackelton E. C., Otieno F. G., Shaner J. L., Smith R. M., Imielinski M., Eckert A. W., Chiavacci R. M., Berkowitz R. I., Hakonarson H., Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP. PLoS ONE 2008 3 3, article e1746 2-s2.0-46249094941 10.1371/journal.pone.0001746 (Pubitemid 351907760)
73. Hakonarson H., Grant S. F. A., Bradfield J. P., Marchand L., Kim C. E., Glessner J. T., Grabs R., Casalunovo T., Taback S. P., Frackelton E. C., Lawson M. L., Robinson L. J., Skraban R., Lu Y., Chiavacci R. M., Stanley C. A., Kirsch S. E., Rappaport E. F., Orange J. S., Monos D. S., Devoto M., Qu H.-Q., Polychronakos C., A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007 448 7153 591 594 2-s2.0-34547621758 10.1038/nature06010 (Pubitemid 47206935)
74. Todd J. A., Walker N. M., Cooper J. D., Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genetics 2007 39 7 857 864 10.1038/ng2068 (Pubitemid 47018195)
75. Grant S. F. A., Hakonarson H., Schwartz S., Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults? Endocrine Reviews 2010 31 2 183 193 2-s2.0-77953643852 10.1210/er.2009-0029
76. Qu H.-Q., Grant S. F. A., Bradfield J. P., Kim C., Frackelton E., Hakonarson H., Polychronakos C., Association analysis of type 2 diabetes loci in type 1 diabetes. Diabetes 2008 57 7 1983 1986 2-s2.0-48249136253 10.2337/db08-0270
77. Nusse R., Varmus H. E., Wnt genes. Cell 1992 69 7 1073 1087 2-s2.0-0026772731 10.1016/0092-8674(92)90630-U
78. Paul S., Dey A., Wnt signaling and cancer development: therapeutic implication. Neoplasma 2008 55 3 165 176 2-s2.0-49049103833
79. Baker N., Morin P. J., Clevers H., The Ying-Yang of TCF/beta-catenin signaling. Advances in Cancer Research 2000 77 1 24
80. Tetsu O., McCormick F., β -catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999 398 6726 422 426 2-s2.0-0033119801 10.1038/18884 (Pubitemid 29180374)
81. Helgason A., Pálsson S., Thorleifsson G., Grant S. F. A., Emilsson V., Gunnarsdottir S., Adeyemo A., Chen Y., Chen G., Reynisdottir I., Benediktsson R., Hinney A., Hansen T., Andersen G., Borch-Johnsen K., Jorgensen T., Schäfer H., Faruque M., Doumatey A., Zhou J., Wilensky R. L., Reilly M. P., Rader D. J., Bagger Y., Christiansen C., Sigurdsson G., Hebebrand J., Pedersen O., Thorsteinsdottir U., Gulcher J. R., Kong A., Rotimi C., Stefánsson K., Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genetics 2007 39 2 218 225 2-s2.0-33846596193 10.1038/ng1960 (Pubitemid 46184353)
82. Palmer N. D., Hester J. M., An S. S., Adeyemo A., Rotimi C., Langefeld C. D., Freedman B. I., Ng M. C. Y., Bowden D. W., Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes 2011 60 2 662 668 2-s2.0-79551609852 10.2337/db10-0134
83. Maller J. B., McVean G., Byrnes J., Bayesian refinement of association signals for 14 loci in 3 common diseases. Nature Genetics 2012 44 12 1294 1301 10.1038/ng.2435
84. Chang Y.-C., Chang T.-J., Jiang Y.-D., Kuo S.-S., Lee K.-C., Chiu K. C., Chuang L.-M., Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes 2007 56 10 2631 2637 2-s2.0-34948845069 10.2337/db07-0421 (Pubitemid 47523272)
85. Ng M. C. Y., Park K. S., Oh B., Tam C. H. T., Cho Y. M., Shin H. D., Lam V. K. L., Ma R. C. W., So W. Y., Cho Y. S., Kim H.-L., Lee H. K., Chan J. C. N., Cho N. H., Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 2008 57 8 2226 2233 2-s2.0-50449104632 10.2337/db07-1583
86. Ng M. C. Y., Tam C. H. T., Lam V. K. L., So W.-Y., Ma R. C. W., Chan J. C. N., Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese. Journal of Clinical Endocrinology and Metabolism 2007 92 9 3733 3737 2-s2.0-34548765645 10.1210/jc.2007-0849 (Pubitemid 47435363)
87. Ren Q., Han X. Y., Wang F., Zhang X. Y., Han L. C., Luo Y. Y., Zhou X. H., Ji L. N., Exon sequencing and association analysis of polymorphisms in TCF7L2 with type 2 diabetes in a Chinese population. Diabetologia 2008 51 7 1146 1152 2-s2.0-44749093346 10.1007/s00125-008-1039-3
88. Yu M., Xu X.-J., Yin J.-Y., Wu J., Chen X., Gong Z.-C., Ren H.-Y., Huang Q., Sheng F.-F., Zhou H.-H., Liu Z.-Q., KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes. Clinical Pharmacology and Therapeutics 2010 87 3 330 335 2-s2.0-77149143848 10.1038/clpt.2009.242
89. Zheng X., Ren W., Zhang S., Liu J., Li S., Li J., Yang P., He J., Su S., Li P., Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population. Molecular Biology Reports 2012 39 1 17 23 2-s2.0-84855186825 10.1007/s11033-011-0705-6
90. Gaulton K. J., Nammo T., Pasquali L., Simon J. M., Giresi P. G., Fogarty M. P., Panhuis T. M., Mieczkowski P., Secchi A., Bosco D., Berney T., Montanya E., Mohlke K. L., Lieb J. D., Ferrer J., A map of open chromatin in human pancreatic islets. Nature Genetics 2010 42 3 255 259 2-s2.0-77649086970 10.1038/ng.530
91. Cauchi S., Froguel P., TCF7L2 genetic defect and type 2 diabetes. Current Diabetes Reports 2008 8 2 149 155 2-s2.0-44849083863 10.1007/s11892-008-0026-x
92. Lyssenko V., Lupi R., Marchetti P., Del Guerra S., Orho-Melander M., Almgren P., Sjögren M., Ling C., Eriksson K.-F., Lethagen Å.-L., Mancarella R., Berglund G., Tuomi T., Nilsson P., Del Prato S., Groop L., Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. Journal of Clinical Investigation 2007 117 8 2155 2163 2-s2.0-34547702501 10.1172/JCI30706 (Pubitemid 47219560)
93. Elbein S. C., Chu W. S., Das S. K., Yao-Borengasser A., Hasstedt S. J., Wang H., Rasouli N., Kern P. A., Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia 2007 50 8 1621 1630 2-s2.0-34447131039 10.1007/s00125-007-0717-x (Pubitemid 47036661)
94. Hansson O., Zhou Y., Renström E., Osmark P., Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes. Current Diabetes Reports 2010 10 6 444 451 2-s2.0-77958468040 10.1007/s11892-010-0149-8
95. Osmark P., Hansson O., Jonsson A., Rönn T., Groop L., Renström E., Unique splicing pattern of the TCF7L2 gene in human pancreatic islets. Diabetologia 2009 52 5 850 854 2-s2.0-64149124055 10.1007/s00125-009-1293-z
96. Le Bacquer O., Kerr-Conte J., Gargani S., TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals. Diabetologia 2012 55 10 2677 2681 10.1007/s00125-012-2660-8
97. Shu L., Sauter N. S., Schulthess F. T., Matveyenko A. V., Oberholzer J., Maedler K., Transcription factor 7-like 2 regulates β -cell survival and function in human pancreatic islets. Diabetes 2008 57 3 645 653 2-s2.0-40949141938 10.2337/db07-0847
98. Liu Z., Habener J. F., Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. Journal of Biological Chemistry 2008 283 13 8723 8735 2-s2.0-43749120731 10.1074/jbc.M706105200
99. Korinek V., Barker N., Moerer P., Van Donselaar E., Huls G., Peters P. J., Clevers H., Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genetics 1998 19 4 379 383 2-s2.0-0031848068 10.1038/1270 (Pubitemid 28357912)
100. Yi F., Brubaker P. L., Jin T., TCF-4 mediates cell type-specific regulation of proglucagon gene expression by β -catenin and glycogen synthase kinase-3 β Journal of Biological Chemistry 2005 280 2 1457 1464 2-s2.0-12544254474 10.1074/jbc.M411487200
101. Boj S. F., van Es J. H., Huch M., Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 2012 151 7 1595 1607 10.1016/j.cell.2012.10.053
102. da Silva Xavier G., Mondragon A., Sun G., Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabetologia 2012 55 10 2667 2676 10.1007/s00125-012-2600-7
103. Savic D., Ye H., Aneas I., Park S.-Y., Bell G. I., Nobrega M. A., Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Research 2011 21 9 1417 1425 2-s2.0-80052527283 10.1101/gr.123745.111
104. Cauchi S., Meyre D., Dina C., Choquet H., Samson C., Gallina S., Balkau B., Charpentier G., Pattou F., Stetsyuk V., Scharfmann R., Staels B., Frühbeck G., Froguel P., Transcription factor TCF7L2 genetic study in the French population: expression in human β -cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006 55 10 2903 2908 2-s2.0-33750889376 10.2337/db06-0474 (Pubitemid 44923694)
105. Kaminska D., Kuulasmaa T., Venesmaa S., Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism. Diabetes 2012 61 11 2807 2813 10.2337/db12-0239
106. Prokunina-Olsson L., Kaplan L. M., Schadt E. E., Collins F. S., Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes. PLoS ONE 2009 4 9, article e7231 2-s2.0-70349636577 10.1371/journal.pone.0007231
107. Prokunina-Olsson L., Welch C., Hansson O., Adhikari N., Scott L. J., Usher N., Tong M., Sprau A., Swift A., Bonnycastle L. L., Erdos M. R., He Z., Saxena R., Harmon B., Kotova O., Hoffman E. P., Altshuler D., Groop L., Boehnke M., Collins F. S., Hall J. L., Tissue-specific alternative splicing of TCF7L2. Human Molecular Genetics 2009 18 20 3795 3804 2-s2.0-70349569023 10.1093/hmg/ddp321
108. Pearson E. R., Donnelly L. A., Kimber C., Whitley A., Doney A. S. F., McCarthy M. I., Hattersley A. T., Morris A. D., Palmer C. N. A., Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes 2007 56 8 2178 2182 2-s2.0-34547585382 10.2337/db07-0440 (Pubitemid 47195841)
109. Holstein A., Hahn M., Körner A., Stumvoll M., Kovacs P., TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes. BMC Medical Genetics 2011 12, article 30 2-s2.0-79951960556 10.1186/1471-2350-12-30
110. Kirpichnikov D., McFarlane S. I., Sowers J. R., Metformin: an update. Annals of Internal Medicine 2002 137 1 25 33 2-s2.0-0037008045 (Pubitemid 34705373)
111. Zhao J., Schug J., Li M., Kaestner K. H., Grant S. F. A., Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo. Diabetologia 2010 53 11 2340 2346 2-s2.0-77957689894 10.1007/s00125-010-1852-3
112. He T.-C., Sparks A. B., Rago C., Hermeking H., Zawel L., Da Costa L. T., Morin P. J., Vogelstein B., Kinzler K. W., Identification of c-MYC as a target of the APC pathway. Science 1998 281 5382 1509 1512 2-s2.0-0032483439 10.1126/science.281.5382.1509 (Pubitemid 28425575)
113. Connor A. E., Baumgartner R. N., Baumgartner K. B., Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities study. Breast Cancer Research and Treatment 2012 136 2 593 602 10.1007/s10549-012-2299-7
114. Lukacs K., Hosszufalusi N., Dinya E., Bakacs M., Madacsy L., Panczel P., The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia 2012 55 3 689 693 2-s2.0-84856697168 10.1007/s00125-011-2378-z
115. Blackman S. M., Commander C. W., Watson C., Genetic modifiers of cystic fibrosis-related diabetes. Diabetes 2013 62 10 3627 3635 10.2337/db13-0510
116. Blackman S. M., Hsu S., Ritter S. E., Naughton K. M., Wright F. A., Drumm M. L., Knowles M. R., Cutting G. R., A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis. Diabetologia 2009 52 9 1858 1865 2-s2.0-68449090520 10.1007/s00125-009-1436-2
117. Furgeri D. T., Marson F. A., Ribeiro A. F., Association between the IVS4G>T mutation in the TCF7L2 gene and susceptibility to diabetes in cystic fibrosis patients. BMC Research Notes 2012 5, article 561 10.1186/1756-0500-5- 561
118. Dina C., Meyre D., Gallina S., Durand E., Körner A., Jacobson P., Carlsson L. M. S., Kiess W., Vatin V., Lecoeur C., Delplanque J., Vaillant E., Pattou F., Ruiz J., Weill J., Levy-Marchal C., Horber F., Potoczna N., Hercberg S., Le Stunff C., Bougnères P., Kovacs P., Marre M., Balkau B., Cauchi S., Chèvre J.-C., Froguel P., Variation in FTO contributes to childhood obesity and severe adult obesity. Nature Genetics 2007 39 6 724 726 2-s2.0-34249777814 10.1038/ng2048 (Pubitemid 46848595)
119. McCormack S., Grant S. F., Genetics of obesity and type 2 diabetes in African Americans. Journal of Obesity 2013 2013 12 396416 10.1155/2013/396416
120. Prentice A. M., Jebb S. A., Beyond body mass index. Obesity Reviews 2001 2 3 141 147 2-s2.0-0035428060 (Pubitemid 33755907)
121. Okada Y., Kubo M., Ohmiya H., Takahashi A., Kumasaka N., Hosono N., Maeda S., Wen W., Dorajoo R., Go M. J., Zheng W., Kato N., Wu J.-Y., Lu Q., Tsunoda T., Yamamoto K., Nakamura Y., Kamatani N., Tanaka T., Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations. Nature Genetics 2012 44 3 302 306 2-s2.0-84857643667 10.1038/ng.1086
122. Wen W., Cho Y. S., Zheng W., Meta-analysis identifies common variants associated with body mass index in East Asians. Nature Genetics 2012 44 3 307 311 10.1038/ng.1087
123. Bollepalli S., Dolan L. M., Deka R., Martin L. J., Association of FTO gene variants with adiposity in African-American adolescents. Obesity 2010 18 10 1959 1963 2-s2.0-77957105975 10.1038/oby.2010.82
124. Scuteri A., Sanna S., Chen W.-M., Uda M., Albai G., Strait J., Najjar S., Nagaraja R., Orrú M., Usala G., Dei M., Lai S., Maschio A., Busonero F., Mulas A., Ehret G. B., Fink A. A., Weder A. B., Cooper R. S., Galan P., Chakravarti A., Schlessinger D., Cao A., Lakatta E., Abecasis G. R., Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genetics 2007 3 7, article e115 2-s2.0-44449162574 10.1371/journal.pgen.0030115 (Pubitemid 47203970)
125. Hassanein M. T., Lyon H. N., Nguyen T. T., Akylbekova E. L., Waters K., Lettre G., Tayo B., Forrester T., Sarpong D. F., Stram D. O., Butler J. L., Wilks R., Liu J., Le Marchand L., Kolonel L. N., Zhu X., Henderson B., Cooper R., McKenzie C., Taylor H. A. Jr., Haiman C. A., Hirschhorn J. N., Fine mapping of the association with obesity at the FTO locus in African-derived populations. Human Molecular Genetics 2010 19 14 2907 2916 2-s2.0-77954513650 10.1093/hmg/ddq178
126. Adeyemo A., Chen G., Zhou J., Shriner D., Doumatey A., Huang H., Rotimi C., FTO genetic variation and association with obesity in West Africans and African Americans. Diabetes 2010 59 6 1549 1554 2-s2.0-77953191271 10.2337/db09-1252
127. Lombard Z., Crowther N. J., van der Merwe L., Appetite regulation genes are associated with body mass index in black South African adolescents: a genetic association study. BMJ Open 2012 2 3, article e000873 10.1136/bmjopen-2012-000873
128. Peters T., Ausmeier K., Dildrop R., Rüther U., The mouse Fused toes (Ft) mutation is the result of a 1.6-Mb deletion including the entire Iroquois B gene cluster. Mammalian Genome 2002 13 4 186 188 2-s2.0-0036220971 10.1007/s00335-001-2142-7 (Pubitemid 34299029)
129. Gerken T., Girard C. A., Tung Y.-C. L., Webby C. J., Saudek V., Hewitson K. S., Yeo G. S. H., McDonough M. A., Cunliffe S., McNeill L. A., Galvanovskis J., Rorsman P., Robins P., Prieur X., Coll A. P., Ma M., Jovanovic Z., Farooqi I. S., Sedgwick B., Barroso I., Lindahl T., Ponting C. P., Ashcroft F. M., O'Rahilly S., Schofield C. J., The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007 318 5855 1469 1472 2-s2.0-36749041363 10.1126/science.1151710 (Pubitemid 350208961)
130. Robbens S., Rouzé P., Cock J. M., Spring J., Worden A. Z., Van De Peer Y., The FTO gene, implicated in human obesity, is found only in vertebrates and marine algae. Journal of Molecular Evolution 2008 66 1 80 84 2-s2.0-38649130998 10.1007/s00239-007-9059-z
131. Tung Y.-C. L., Yeo G. S. H., From GWAS to biology: lessons from FTO. Annals of the New York Academy of Sciences 2011 1220 1 162 171 2-s2.0-79952474482 10.1111/j.1749-6632.2010.05903.x
132. Church C., Moir L., McMurray F., Girard C., Banks G. T., Teboul L., Wells S., Brüning J. C., Nolan P. M., Ashcroft F. M., Cox R. D., Overexpression of FTO leads to increased food intake and results in obesity. Nature Genetics 2010 42 12 1086 1092 2-s2.0-78649459183 10.1038/ng.713
133. Cecil J. E., Tavendale R., Watt P., Hetherington M. M., Palmer C. N. A., An obesity-associated FTO gene variant and increased energy intake in children. The New England Journal of Medicine 2008 359 24 2558 2566 2-s2.0-57749121512 10.1056/NEJMoa0803839
134. Wardle J., Carnell S., Haworth C. M. A., Farooqi I. S., O'Rahilly S., Plomin R., Obesity associated genetic variation in FTO is associated with diminished satiety. Journal of Clinical Endocrinology and Metabolism 2008 93 9 3640 3643 2-s2.0-51649128621 10.1210/jc.2008-0472
135. Church C., Lee S., Bagg E. A. L., McTaggart J. S., Deacon R., Gerken T., Lee A., Moir L., Mecinović J., Quwailid M. M., Schofield C. J., Ashcroft F. M., Cox R. D., A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genetics 2009 5 8 2-s2.0-70149100469 10.1371/journal.pgen.1000599 e1000599
136. Fischer J., Koch L., Emmerling C., Vierkotten J., Peters T., Brüning J. C., Rüther U., Inactivation of the FTO gene protects from obesity. Nature 2009 458 7240 894 898 2-s2.0-67349211789 10.1038/nature07848
137. Elks C. E., Loos R. J., Hardy R., Adult obesity susceptibility variants are associated with greater childhood weight gain and a faster tempo of growth: the 1946 British Birth Cohort study. The American Journal of Clinical Nutrition 2012 95 5 1150 1156 10.3945/ajcn.111.027870
138. Elks C. E., Loos R. J. F., Sharp S. J., Langenberg C., Ring S. M., Timpson N. J., Ness A. R., Smith G. D., Dunger D. B., Wareham N. J., Ong K. K., Genetic markers of adult obesity risk are associated with greater early infancy weight gain and growth. PLoS Medicine 2010 7 5 1000284 2-s2.0-77953270825 10.1371/journal.pmed.1000284
139. Hardy R., Wills A. K., Wong A., Elks C. E., Wareham N. J., Loos R. J. F., Kuh D., Ong K. K., Life course variations in the associations between FTO and MC4R gene variants and body size. Human Molecular Genetics 2010 19 3 545 552 2-s2.0-77949894041 10.1093/hmg/ddp504